| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_827e0ca23caed963cb540e536d5466e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_709b4a26ef028713f9b302509eb824d7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-7155 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0056 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-88 |
| filingDate |
2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_486b76f87ea69a607f6ef260f7bf7ae3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46d7f15605054b2cefdc4c5d087b5946
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c4137115e2c482116543c37cdb08690 |
| publicationDate |
2020-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020097070-A1 |
| titleOfInvention |
Mutagenized il13 and methods of use |
| abstract |
Disclosed is a conjugated mutagenized IL13, comprising a mutagenized IL13 (mIL13) conjugated to a conjugatable agent. Also disclosed is an extracellular vesicle complex, comprising an extracellular vesicle complexed with a conjugated mutagenized IL13. Also disclosed are methods of detecting an IL13-specific receptor in a sample, comprising contacting a portion of a sample with a conjugated mutagenized IL13 (mIL13) or an extracellular vesicle complex. Also disclosed are methods for diagnosing cancer in a subject, comprising administering a conjugated mutagenized IL13 or an extracellular complex, and diagnosing the subject with cancer when a level of conjugated mIL13 binding to a target of the subject is detected. Also disclosed are kits comprising a conjugated mutagenized IL 13 or an extracellular complex. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023086896-A1 |
| priorityDate |
2018-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |